Effect of the Addition of Anti-CD3 and Anti-HLA Class I MoAbs on the Cytolytic Activity of LB-Reactive TCC Against Autologous Pretransplant LB
| TCC No. . | Phenotype . | % of Specific Lysis . | ||
|---|---|---|---|---|
| Untreated . | +Anti-CD3 . | +Anti-HLA Class I . | ||
| 6* | TCR αβ+/CD8+ | 35 | 2 | 6 |
| 8* | TCR αβ+/CD8+ | 68 | 9 | 8 |
| 13* | TCR αβ+/CD8−/CD4− | 26 | 32 | 28 |
| 15* | TCR γδ+/CD8+ | 26 | 30 | 21 |
| 2† | TCR αβ+/CD8+ | 58 | 26 | 8 |
| 7† | TCR αβ+/CD8+ | 36 | 6 | 4 |
| 15† | TCR γδ+/CD8+ | 15 | 12 | 17 |
| 18† | TCR γδ+/CD8−/CD4− | 35 | 30 | 25 |
| TCC No. . | Phenotype . | % of Specific Lysis . | ||
|---|---|---|---|---|
| Untreated . | +Anti-CD3 . | +Anti-HLA Class I . | ||
| 6* | TCR αβ+/CD8+ | 35 | 2 | 6 |
| 8* | TCR αβ+/CD8+ | 68 | 9 | 8 |
| 13* | TCR αβ+/CD8−/CD4− | 26 | 32 | 28 |
| 15* | TCR γδ+/CD8+ | 26 | 30 | 21 |
| 2† | TCR αβ+/CD8+ | 58 | 26 | 8 |
| 7† | TCR αβ+/CD8+ | 36 | 6 | 4 |
| 15† | TCR γδ+/CD8+ | 15 | 12 | 17 |
| 18† | TCR γδ+/CD8−/CD4− | 35 | 30 | 25 |